Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO TrialTalia Golan, Michael J. Hall, Teresa Macarulla et al.|Journal of Clinical Oncology|2020Cited by 73
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirementsManuela Braun, Mark Milton, Claudia Lange et al.|Molecular Therapy — Methods & Clinical Development|2024Cited by 25